Log Type Authored on Log Message Log Node Authored by
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Anonymous
User created User created Anonymous
User created User created Anonymous
User created User created Anonymous
Newsletter opened Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Anonymous
OWA Status israel@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Anonymous
Newsletter opened Opened Anonymous
OWA Status Updating trust level from 1 to 2 Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
User created User created Anonymous
Newsletter opened Opened Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
OWA Status Updating trust level from 1 to 2 Anonymous
OWA Status Updating trust level from 1 to 4 Anonymous
User created User created Anonymous
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19 Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Log Type Authored on Log Message Log Node Authored by
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Anonymous
User created User created Anonymous
User created User created Anonymous
User created User created Anonymous
Newsletter opened Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Anonymous
OWA Status israel@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Anonymous
Newsletter opened Opened Anonymous
OWA Status Updating trust level from 1 to 2 Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
User created User created Anonymous
Newsletter opened Opened Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
OWA Status Updating trust level from 1 to 2 Anonymous
OWA Status Updating trust level from 1 to 4 Anonymous
User created User created Anonymous
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19 Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous